# A Randomised Phase 2 Study of AZD2014 Versus Everolimus in Patients with VEGF-Refractory Metastatic Clear Cell Renal Cancer

**Type:** Papers  
**Canonical URL:** https://scholariq.org/papers/a-randomised-phase-2-study-of-azd2014-versus-everolimus-in-patients-with-vegf/

## Facts

| Field | Value |
| --- | --- |
| Author Names | Thomas Powles,Matthew Wheater,Omar Din,T. Geldart,Ekaterini Boleti,Andrew Stockdale,Santhanam Sundar,Angus Robinson,Imtiaz Ahmed,Akhila Wimalasingham,Wendy Burke,Shah‐Jalal Sarker,Syed A. Hussain,Christy Ralph |
| Citations | 100 |
| DOI | 10.1016/j.eururo.2015.08.035 |
| Fields | Biochemistry, Genetics and Molecular Biology,Medicine |
| Open Access | false |
| OA Status | closed |
| OpenAlex ID | https://openalex.org/W2115010775 |
| PMID | 26364551 |
| Type | article |
| Year | 2015 |

## Paper authors

- [Shah‐Jalal Sarker](https://scholariq.org/researchers/shah-jalal-sarker/)

## Paper journal

- [European Urology](https://scholariq.org/journals/european-urology/)

## Paper primary topic

- [Renal cell carcinoma treatment](https://scholariq.org/topics/renal-cell-carcinoma-treatment/)

## Paper topics

- [Renal cell carcinoma treatment](https://scholariq.org/topics/renal-cell-carcinoma-treatment/)
- [PI3K/AKT/mTOR signaling in cancer](https://scholariq.org/topics/pi3k-akt-mtor-signaling-in-cancer/)
- [Tuberous Sclerosis Complex Research](https://scholariq.org/topics/tuberous-sclerosis-complex-research/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.